Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-21-067905

Chief Financial Officer bought 3,800 shares at $2.35 ($8,930)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamm John M. Chief Financial Officer 2021-11-23 Purchase +3,800 $2.35 $8,930 6,800 D
Open-market purchases · 3,800 sh · avg $2.35 · $8,930
Loading xslF345X03/doc4.xml…